U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX19742061: GSM7110256: Q15_mCherry_EXP2_rep3; Mus musculus; RNA-Seq
1 ILLUMINA (Illumina NovaSeq 6000) run: 7.5M spots, 762.5M bases, 253.1Mb downloads

External Id: GSM7110256_r1
Submitted by: NCBI/NLM/NIH
Study: A genome-wide screening in pluripotent cells identifies Mtf1 as a suppressor of mutant huntingtin toxicity
show Abstracthide Abstract
Huntington's disease (HD) is an inherited and incurable neurodegenerative disorder caused by CAG repeat expansions in the huntingtin (HTT) gene. The resulting mutant HTT protein alters cellular physiology at multiple levels, inducing toxicity and cell death. The mechanisms directly causing toxicity are partially understood, thus precluding the development of effective therapeutic strategies. Here we identified novel suppressors of mutant HTT toxicity by performing a genome-wide screen in pluripotent stem cells, followed by hit validation both in zebrafish and mouse HD models. The candidate suppressors identified were strongly enriched for HD-associated processes. We focused on Metal regulatory transcription factor 1 (Mtf1), a transcription factor controlling metal homeostasis in the cell. Forced expression of Mtf1 counteracts cell death, oxidative stress and transcriptional alterations caused by mutant HTT in pluripotent cells. In zebrafish, Mtf1 reduces malformations and apoptosis induced by mutant HTT, while Mtf1 delivery by Adeno-Associated viral (AAV) vectors ablated motor defects observed in an HD mouse model. Our data reveal that delivery of Mtf1 might act as a novel therapeutic strategy against HD and potentially other neurodegenerative disorders. Overall design: Library Preparation Total RNA was quantified using the Qubit 2.0 fluorimetric Assay (Thermo Fisher Scientific). Libraries were prepared from (125* - 250** - 250***) ng of total RNA using a 3'DGE mRNA-seq (research*/clinical**/diagnostic***) grade sequencing service (Next Generation Diagnostics srl)1 which included library preparation, quality assessment and sequencing on a NovaSeq 6000 sequencing system using a single-end, 100 cycle strategy (Illumina Inc.). Bioinformatics workflow The raw data were analyzed by Next Generation Diagnostics srl proprietary 3'DGE mRNA-seq pipeline (v2.0) which involves a cleaning step by quality filtering and trimming, alignment to the reference genome and counting by gene. We have filtered out all genes having < 1 cpm in less than n_min samples and Perc MM reads > 20% simultaneously. Differential expression analysis was performed using edgeR.
Sample: Q15_mCherry_EXP2_rep3
SAMN33845413 • SRS17108035 • All experiments • All runs
Organism: Mus musculus
Library:
Name: GSM7110256
Instrument: Illumina NovaSeq 6000
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC
Selection: cDNA
Layout: SINGLE
Construction protocol: Total RNA was isolated using Total RNA Purification kit (Norgen Biotek), according to manufactorer's protocol. 3'DGE mRNA-seq (research*/clinical**/diagnostic***) grade sequencing service (Next Generation Diagnostics srl)
Runs: 1 run, 7.5M spots, 762.5M bases, 253.1Mb
Run# of Spots# of BasesSizePublished
SRR239322087,549,690762.5M253.1Mb2023-05-30

ID:
27058403

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...